Blythe Buchanan (she/her)

Blythe Buchanan has extensive work experience in regulatory affairs and pharmaceutical industries. Blythe is currently the VP, Head of Regulatory Affairs at Corium, Inc. since 2023. Prior to this, Blythe worked at Biogen as an Executive Director, Head of Regulatory Affairs Advertising and Promotion from 2021 to 2023, and as a Senior Director in the same department from 2017 to 2021. Blythe also served as the Interim Head of U.S. Regulatory Strategy for Alzheimer's from 2020 to 2021 and as an Associate Director in Regulatory Affairs - Advertising Labeling and Promotion from 2015 to 2017. Before joining Biogen, they worked at Endo Pharmaceuticals from 2015 to 2015 as a Senior Manager in Regulatory Affairs, Advertising and Promotion. Blythe also has experience in regulatory affairs and promotional review from their time at Auxilium Pharmaceuticals from 2013 to 2015. Earlier in their career, they held various roles in competitive intelligence, commercial analytics, sales training and development at different companies including Endo Health Solutions, Indevus Pharmaceuticals, Sepracor Pharmaceuticals, Eli Lilly, and State Farm Insurance.

Blythe Buchanan (she/her) pursued their undergraduate education at Wesleyan College from 1991 to 1995. During this time, they obtained a Bachelor's degree in Psychology and Sociology.